156 related articles for article (PubMed ID: 25246803)
21. Downregulation of microRNA-217 and microRNA-646 acts as potential predictor biomarkers in progression, metastasis, and unfavorable prognosis of human osteosarcoma.
Azam AT; Bahador R; Hesarikia H; Shakeri M; Yeganeh A
Tumour Biol; 2016 May; 37(5):5769-73. PubMed ID: 26224480
[TBL] [Abstract][Full Text] [Related]
22. Interleukin-1β/nuclear factor-κB signaling promotes osteosarcoma cell growth through the microRNA-181b/phosphatase and tensin homolog axis.
Wang W; Wang Z; Chen S; Zang X; Miao J
J Cell Biochem; 2019 Feb; 120(2):1763-1772. PubMed ID: 30977354
[TBL] [Abstract][Full Text] [Related]
23. Aberrant expression of microRNA-99a and its target gene mTOR associated with malignant progression and poor prognosis in patients with osteosarcoma.
Zhao J; Chen F; Zhou Q; Pan W; Wang X; Xu J; Ni L; Yang H
Onco Targets Ther; 2016; 9():1589-97. PubMed ID: 27073323
[TBL] [Abstract][Full Text] [Related]
24. The expression and function of miRNA-451 in osteosarcoma.
Yuan J; Lang J; Liu C; Zhou K; Chen L; Liu Y
Med Oncol; 2015 Jan; 32(1):324. PubMed ID: 25471786
[TBL] [Abstract][Full Text] [Related]
25. MiR-221 increases osteosarcoma cell proliferation, invasion and migration partly through the downregulation of PTEN.
Zhu J; Liu F; Wu Q; Liu X
Int J Mol Med; 2015 Nov; 36(5):1377-83. PubMed ID: 26397386
[TBL] [Abstract][Full Text] [Related]
26. miR-17 inhibitor suppressed osteosarcoma tumor growth and metastasis via increasing PTEN expression.
Gao Y; Luo LH; Li S; Yang C
Biochem Biophys Res Commun; 2014 Feb; 444(2):230-4. PubMed ID: 24462867
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-494 promotes cervical cancer proliferation through the regulation of PTEN.
Yang YK; Xi WY; Xi RX; Li JY; Li Q; Gao YE
Oncol Rep; 2015 May; 33(5):2393-401. PubMed ID: 25738254
[TBL] [Abstract][Full Text] [Related]
28. Combined elevation of microRNA-196a and microRNA-196b in sera predicts unfavorable prognosis in patients with osteosarcomas.
Zhang C; Yao C; Li H; Wang G; He X
Int J Mol Sci; 2014 Apr; 15(4):6544-55. PubMed ID: 24747591
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-335 and its target Rock1 synergistically influence tumor progression and prognosis in osteosarcoma.
Wang Y; Wang N; Zeng X; Sun J; Wang G; Xu H; Zhao W
Oncol Lett; 2017 May; 13(5):3057-3065. PubMed ID: 28521412
[TBL] [Abstract][Full Text] [Related]
30. Low miR-34a and miR-192 are associated with unfavorable prognosis in patients suffering from osteosarcoma.
Wang Y; Jia LS; Yuan W; Wu Z; Wang HB; Xu T; Sun JC; Cheng KF; Shi JG
Am J Transl Res; 2015; 7(1):111-9. PubMed ID: 25755833
[TBL] [Abstract][Full Text] [Related]
31. miR-92a promotes tumor growth of osteosarcoma by targeting PTEN/AKT signaling pathway.
Xiao J; Yu W; Hu K; Li M; Chen J; Li Z
Oncol Rep; 2017 Apr; 37(4):2513-2521. PubMed ID: 28260104
[TBL] [Abstract][Full Text] [Related]
32. Downregulation of microRNA-26a is associated with metastatic potential and the poor prognosis of osteosarcoma patients.
Song QC; Shi ZB; Zhang YT; Ji L; Wang KZ; Duan DP; Dang XQ
Oncol Rep; 2014 Mar; 31(3):1263-70. PubMed ID: 24452597
[TBL] [Abstract][Full Text] [Related]
33. Dysregulation of microRNA-106a-5p-RUNX1 axis associates with clinical progression and prognosis of osteosarcoma patients.
Chen K; Pan G
Pathol Res Pract; 2019 Dec; 215(12):152686. PubMed ID: 31711673
[TBL] [Abstract][Full Text] [Related]
34. microRNA-93 promotes cell proliferation via targeting of PTEN in Osteosarcoma cells.
Kawano M; Tanaka K; Itonaga I; Ikeda S; Iwasaki T; Tsumura H
J Exp Clin Cancer Res; 2015 Aug; 34(1):76. PubMed ID: 26243299
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-221 induces cell survival and cisplatin resistance through PI3K/Akt pathway in human osteosarcoma.
Zhao G; Cai C; Yang T; Qiu X; Liao B; Li W; Ji Z; Zhao J; Zhao H; Guo M; Ma Q; Xiao C; Fan Q; Ma B
PLoS One; 2013; 8(1):e53906. PubMed ID: 23372675
[TBL] [Abstract][Full Text] [Related]
36. Downregulation of miR-136 promotes the progression of osteosarcoma and is associated with the prognosis of patients with osteosarcoma.
Chu Y; Hu X; Wang G; Wang Z; Wang Y
Oncol Lett; 2019 Jun; 17(6):5210-5218. PubMed ID: 31186737
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic and prognostic potentials of microRNA-27a in osteosarcoma.
Tang J; Zhao H; Cai H; Wu H
Biomed Pharmacother; 2015 Apr; 71():222-6. PubMed ID: 25960240
[TBL] [Abstract][Full Text] [Related]
38. Increased expression of microRNA-148a in osteosarcoma promotes cancer cell growth by targeting PTEN.
Zhang H; Wang Y; Xu T; Li C; Wu J; He Q; Wang G; Ding C; Liu K; Tang H; Ji F
Oncol Lett; 2016 Nov; 12(5):3208-3214. PubMed ID: 27899984
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-208a-3p promotes osteosarcoma progression via targeting PTEN.
Fu Y; Wang Y; Bi K; Yang L; Sun Y; Li B; Liu Z; Zhang F; Li Y; Feng C; Bi Z
Exp Ther Med; 2020 Dec; 20(6):255. PubMed ID: 33178353
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-196a overexpression promotes cell proliferation and inhibits cell apoptosis through PTEN/Akt/FOXO1 pathway.
Shang Y; Wang LQ; Guo QY; Shi TL
Int J Clin Exp Pathol; 2015; 8(3):2461-72. PubMed ID: 26045752
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
